
Catch up on what happened in optometry during the week of November 13-November 17.

Using the NEI protocol for addressing corneal staining, researchers used 5 microliters of 2%, non preserved fluorescein and then evaluated corneal staining.

This is just one of many times the FDA has issued a warning to companies for the sale of unapproved ophthalmic products in 2023.

Hear about the new innovations on the market—and coming soon—from Alcon.

Is telemedicine through retinal images a solution to earlier intervention and increased access to care? Fortunately—and unfortunately—yes.

ONE by ONE and Biotrue Eye Care Recycling programs from Bausch + Lomb have collected over 464,100 pounds of used contact lens materials that would have otherwise been sent to a landfill.

A rapid-fire, top-level review of what happened in optometry in 2023.

Counsel your at-risk patients on strategies to minimize severe hypoglycemia.

Hear how this daily disposable silicone hydrogel option fits patients' busy and active lifestyles.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.

Hear how the Clek study continues to play a role in today's keratoconus care.

Catch up on what happened in optometry during the week of November 6-November 11.

By taking a proactive approach to treatment, identify the “silent sufferers.”

Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.

The 2023 American Academy of Optometry annual meeting showcased excellent science and insightful education.

Clark Chang, OD, MSA, MSC, FAAO, shares highlights from his 2023 AAOpt presentation, which he co-presented with Christine Sindt, OD, FAAO.

For patients with keratoconus-related inflammation, an intracanalicular steroid insert rivals the effectiveness of eye drops while boosting adherence.

A free online software, EyeMedsNow offers ECPs access to an extensive database of prescription and OTC medications.

Catch up on what happened in optometry during the week of October 30-November 3.

According to Sun Pharmaceutical Industries, the study design mirrors real-world experience with dry eye disease, including allowing use of artificial tears and measurement of CFS in all 5 corneal zones.

Patients who have signs or symptoms of an eye infection after using these products should talk to their health care provider or seek medical care immediately.


These continued studies also demonstrate a well-tolerated safety profile in a broad population of more than 1,200 patients.

The FDA recalled 26 eye drops due to risk of infection and possible vision loss.

AI may play an important role in patient communication and treatment.

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.

These toxic offenders can be found in various pathways and can pollute the ocular surface.

Catch up on what happened in optometry during the week of October 23-October 27.

According to Genentech, RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular edema. The approval is based on two Phase III studies demonstrating early and sustained vision improvements that were non-inferior to aflibercept.

Educating patients about the importance of consistent care is key.